At the recent (17 & 19 May 2007) Scientific Meeting of the Australian Gynaecology and Endoscopic Society, the presentation of BoiMD's ADAPT product won the "Best New Technology" Award.
There's still not much interest in this stock, but accolades like this one surely have to prick up some ears somewhere. The CSO has also been invited to make an oral presentation to the Society for Heart Valve Disease in New York in mid June.
"The ADAPT® Advanced Tissue Process not only has application in Heart Valve manufacture but
has applications in many other surgical specialties such as orthopaedics, abdominal and pelvic fl oor
reconstructions, and cardiovascular applications where treated biomaterials are used as surgical
implants for organ and tissue repair."
I don't own any shares in this one, but I'll be putting it on a close watch leading up to, and beyond the New York presentation.